Browsing Tag
United States
1092 posts
Novo Nordisk eyes FDA approval for high-dose 7.2mg Wegovy after STEP UP trial shows 21% weight loss
Novo Nordisk seeks U.S. approval for 7.2mg Wegovy after 21% average weight loss in trials. Can it outpace Eli Lilly’s Zepbound in the obesity drug race?
Amazon sets ‘Prime Big Deal Days’ for October 7–8 to jump-start 2025 holiday shopping
Amazon confirms Prime Big Deal Days for Oct 7–8, with AI shopping tools, early deals, and stock momentum shaping this year’s holiday retail rush.
NanoVibronix (NASDAQ: NAOV) registers 1.35m shares for resale after reverse split, fueling volatility talk
NanoVibronix registers 1.35M shares for resale as holders seek liquidity. Will the post-split overhang pressure NAOV or offer trading opportunity?
Ferguson Enterprises (NYSE: FERG) Q4 earnings beat: $3.48 EPS, $8.5bn revenue—what’s behind the surprise?
Ferguson Enterprises (NYSE: FERG) posts $3.48 EPS and $8.5B revenue beat—find out how non-residential demand and margin control lifted results.
Why Medtronic raised €1.5bn in senior notes—and what it means for its 2025 debt load
Medtronic raised €1.5 billion in senior notes to refinance 2025 debt. Find out what it signals for investors and long-term financial strategy.
Tronox just raised $400m at 9.125%—but is it refinancing smart or a warning sign?
Tronox raises $400M via 9.125% notes to refinance debt. Explore what this means for its balance sheet, stock, and the titanium dioxide industry.
Why did Ameren Illinois issue another $350m in 2055 bonds and what’s the long-term debt strategy?
Ameren Illinois issues $350M 5.625% first mortgage bonds due 2055 at 5.405% yield to refinance short-term debt. Find out what this means for AEE investors.
Trump vs. The New York Times at $15bn: Can this case rewrite press freedom and rattle Wall Street?
Trump sues The New York Times for $15B. See legal stakes, NYT stock reaction, and why the “actual malice” rule could define the case’s outcome.
Docusign secures FedRAMP Moderate authorization to accelerate federal digital agreement adoption
Docusign secures FedRAMP Moderate clearance for its IAM platform, opening federal market doors and boosting investor confidence.
China probes U.S. chip exports: Why Texas Instruments and Analog Devices face new trade risk in 2025
China probes U.S. chip exports over dumping and discrimination—see which firms are hit and how trade talks may reshape the global semiconductor balance.